Game-Changing Study Proves Combination of Nutrients and Vitamins Boosts Male Fertility Parameters by 76%

A combination of multivitamins, minerals, essential amino acids, ginseng, and lycopene boosted sperm count by 75.76% in Indian males with a baseline sperm count of less than 5 million / ml


New Delhi : In extreme instances of male infertility, a combination of anti-oxidant micronutrients and vitamins enhanced male reproductive parameters by 76%, according to a research by Indian nutraceutical giant Meyer Vitabiotics. A combination of multivitamins, minerals, essential amino acids, ginseng, and lycopene boosted sperm count by 75.76% in Indian males with a baseline sperm count of less than 5 million / ml. Over the course of three months, researchers analysed data from 300 males in India who were experiencing varying degrees and causes of infertility. The positive findings provide support to multiple micronutrients treatment, which is often overlooked in India.

Meyer Vitabiotics undertook a randomised, double-blind, placebo-controlled clinical experiment at 10 locations in India examining the effects of antioxidants on sperm quality indicators as count, motility, and DNA fragmentation.

Using nutraceuticals to treat male infertility has been given a significant boost by this research.

Clinical and Translational Pharmacology, an international journal, published the results of the research.

The trial’s primary investigator, Dr. Ameet Patki, has said,

Twenty-three percent of all infertility cases may be traced back to a single cause: men. The clinical burden of male factor infertility is significant. The most common causes of male infertility are sperm abnormalities such sperm count (Oligospermia), sperm motility (Asthenozoospermia), and sperm grouping (Teratozoospermia). Treatment options for male infertility include surgery, hormone therapy, and medication, but these approaches come with their own set of challenges, including greater costs, questionable clinical efficacy, and unpleasant side effects. Clinicians and scientists are becoming interested in antioxidants for improving male fertility indicators. Infertile males have been shown to have fragmented sperm DNA. Sperm quality is severely diminished if the percentage is more than 30% below the average. This study stands out from others in the field since it uses DFI as an outcome measure both before and after therapy.

Mr. Rohit Shelatkar, Vice-President of Meyer Vitabiotics says,

“Infertility is a serious concern worldwide. As per the earlier published comprehensives it is reinforced that there is vital role of diet and antioxidant supplementation in male factor infertility. The limitations of current treatment options calls for a convenient, less costly and yet clinically effective option. Considering the gaining interest of fraternity in antioxidant therapy and the need for systematic scientific evidence, the present study was proposed to evaluate the efficacy of antioxidant blend in sub-fertile males. The experiential use of antioxidants in male infertility is aimed at improving semen parameters and DNA Fragmentation Index (DFI), enhancing the probability of conception. The frequently prescribed compounds include vitamins E & C, carnitine, N-acetyl cysteine, selenium, and zinc. Interventional antioxidant blend through a single tablet of Oligocare forte plus, also called Wellman Conception in the UK, is a combination of micronutrients, essential amino acids, antioxidants, and vitamins that are essential for the male reproductive system”.

The clinical trial, was aimed to evaluate the safety, efficacy, and tolerability of Oligocare forte plus in sub-fertile males. Along with Dr. Ameet Patki, Dr. Monica singh, Dr. Sweta Agarwal, Dr. Venugopal M, Dr. Shashikant Umbardand, Dr. Apoorva Reddy, Dr. Priya Kannan, Dr. Srilatha gorthi, Dr. Gautam Khastgir, Dr. Anita Kulshreshtha were the investigators at other sites. Their dedication and efforts remarkably contributed to achieve study objectives and gain valuable insights into this research.

The study involved 300 participants who met the eligibility criteria and the results obtained have been highly promising. It was one of its kind multi-centric trial in sub-fertile male population conducted with meticulous adherence to good clinical practices (GCP) and all relevant regulations and guidelines.

About Meyer Vitabiotics:

Meyer Vitabiotics is part of the UK’s No. 1 Vitamin Company Vitabiotics Ltd, headquartered in London. The organization has proven itself as one of the leading pharmaceutical manufacturers with a range of pioneering Vitamin and Mineral Supplements available in more than 110 countries. Most prominent products like Calcimax, Colicaid, Jointace, Wellman, Wellwoman, Ultra D3, Perfectil, Pregnacare, Menopace etc. are all market leading supplements in their respective segments. Meyer Vitabiotics is committed to excel in human health care, research and providing Nutrition Supplements for all age groups. We believe in the science of Nutrition backed by clinical evidences that reinforces the facts of safety and effectiveness of nutraceutical supplementation for better therapeutic outcomes.